These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34233466)

  • 21. Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial.
    Krishnan K; Scutt P; Woodhouse L; Adami A; Becker JL; Cala LA; Casado AM; Chen C; Dineen RA; Gommans J; Koumellis P; Christensen H; Collins R; Czlonkowska A; Lees KR; Ntaios G; Ozturk S; Phillips SJ; Sprigg N; Szatmari S; Wardlaw JM; Bath PM;
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1017-1026. PubMed ID: 26853137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT).
    Anderson CS; Huang Y; Arima H; Heeley E; Skulina C; Parsons MW; Peng B; Li Q; Su S; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Morgenstern LB; Chalmers J; Wang JG;
    Stroke; 2010 Feb; 41(2):307-12. PubMed ID: 20044534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
    Berthet K; Neal BC; Chalmers JP; MacMahon SW; Bousser MG; Colman SA; Woodward M;
    Blood Press; 2004; 13(1):7-13. PubMed ID: 15083634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
    Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical analysis of factors predisposing the recurrence of primary intracerebral hemorrhage in patients taking anti-hypertensive drugs: a prospective cohort study.
    Kim YZ; Park YH; Song YG; Kim KH
    Clin Neurol Neurosurg; 2013 May; 115(5):578-86. PubMed ID: 22877684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
    Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
    Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
    Hasegawa Y; Yamaguchi T; Omae T; Woodward M; Chalmers J;
    Hypertens Res; 2004 Mar; 27(3):147-56. PubMed ID: 15080373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
    Chalmers J; MacMahon S
    J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: population-based study.
    Li L; Luengo-Fernandez R; Zuurbier SM; Beddows NC; Lavallee P; Silver LE; Kuker W; Rothwell PM
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):580-585. PubMed ID: 32165376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage.
    Castello JP; Teo KC; Abramson JR; Keins S; Takahashi CE; Leung IYH; Leung WCY; Wang Y; Kourkoulis C; Pavlos Myserlis E; Warren AD; Henry J; Chan KH; Cheung RTF; Ho SL; Gurol ME; Viswanathan A; Greenberg SM; Anderson CD; Lau KK; Rosand J; Biffi A
    J Am Heart Assoc; 2022 Mar; 11(6):e024158. PubMed ID: 35253479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial.
    Czernichow S; Ninomiya T; Huxley R; Kengne AP; Batty GD; Grobbee DE; Woodward M; Neal B; Chalmers J
    Hypertension; 2010 May; 55(5):1193-8. PubMed ID: 20212271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
    PROGRESS Collaborative Group
    Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trial.
    Neutel JM; Weber MA; Julius S; Cohn JN; Turlapaty P; Shen Y; Guo W; Batchelor A; Lagast H
    Am J Cardiovasc Drugs; 2004; 4(5):335-41. PubMed ID: 15449975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
    Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
    Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of Long-Term Blood Pressure Control After Intracerebral Hemorrhage: Challenges and Opportunities.
    Mullen MT; Anderson CS
    Stroke; 2022 Jul; 53(7):2142-2151. PubMed ID: 35657328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition.
    Coull AJ; Rothwell PM
    Stroke; 2004 Aug; 35(8):1925-9. PubMed ID: 15192248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress.
    Anderson CS; Rodgers A; de Silva HA; Martins SO; Klijn CJ; Senanayake B; Freed R; Billot L; Arima H; Thang NH; Zaidi WAW; Kherkheulidze T; Wahab K; Fisher U; Lee TH; Chen C; Pontes-Neto O; Robinson T; Wang J; Naismith S; Song L; Schreuder FH; Lindley RI; Woodward M; MacMahon S; Salman RA; Chow CK; Chalmers J
    Int J Stroke; 2022 Dec; 17(10):1156-1162. PubMed ID: 34994269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Insights into Blood Pressure Control for Intracerebral Haemorrhage.
    Manning LS; Robinson TG
    Front Neurol Neurosci; 2015; 37():35-50. PubMed ID: 26588787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage.
    Zheng D; Sato S; Arima H; Heeley E; Delcourt C; Cao Y; Chalmers J; Anderson CS;
    Am J Kidney Dis; 2016 Jul; 68(1):94-102. PubMed ID: 26948991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.